Specifically, aberrant mucin glycosylation on cancer cells leads to the expression of atypical epitopes, resulting in the recognition and binding of cancer cell membrane glycosylation patterns that trigger apoptosis of cancer-specific effector T-cells [47]. Here, MUC5AC is linked to cancer.